Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIM1 | P11309 | 4/20 | 0.69 |
| ▸ | MAP4K2 | Q12851 | 4/20 | 0.69 |
| ▸ | DYRK3 | O43781 | 3/20 | 0.69 |
| ▸ | MAP4K4 | O95819 | 3/20 | 0.69 |
| ▸ | CDK1 | P06493 | 3/20 | 0.69 |
| ▸ | CSNK1A1 | P48729 | 3/20 | 0.69 |
| ▸ | GSK3A | P49840 | 3/20 | 0.69 |
| ▸ | GSK3B | P49841 | 3/20 | 0.69 |
| ▸ | PRKX | P51817 | 3/20 | 0.69 |
| ▸ | NEK4 | P51957 | 3/20 | 0.69 |
| ▸ | CSNK2A1 | P68400 | 3/20 | 0.69 |
| ▸ | CSNK1G2 | P78368 | 3/20 | 0.69 |
| ▸ | DYRK1A | Q13627 | 3/20 | 0.69 |
| ▸ | HIPK4 | Q8NE63 | 3/20 | 0.69 |
| ▸ | SLK | Q9H2G2 | 3/20 | 0.69 |
| ▸ | HIPK2 | Q9H2X6 | 3/20 | 0.69 |
| ▸ | CLK4 | Q9HAZ1 | 3/20 | 0.69 |
| ▸ | CSNK1G1 | Q9HCP0 | 3/20 | 0.69 |
| ▸ | MAP3K20 | Q9NYL2 | 3/20 | 0.69 |
| ▸ | STK17A | Q9UEE5 | 3/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7056037 | 0.83 | PIM1 (0.66) | PIM1MAP4K2DYRK3MAP4K4CDK1 | |
| SCHEMBL7053779 | 0.81 | PIM1 (1.00) | PIM1MAP4K2DYRK3MAP4K4CDK1 | |
| SCHEMBL7058872 | 0.79 | PIM1 (0.66) | PIM1MAP4K2DYRK3MAP4K4CDK1 | |
| SCHEMBL7053764 | 0.78 | CDK8 (0.69) | PIM1MAP4K2DYRK3MAP4K4CDK1 | |
| SCHEMBL7053286 | 0.78 | CDK8 (0.61) | PIM1MAP4K2DYRK3MAP4K4CDK1 | |
| SCHEMBL7055183 | 0.78 | CDK8 (0.65) | PIM1MAP4K2DYRK3MAP4K4CDK1 | |
| SCHEMBL7051781 | 0.77 | CDK8 (0.67) | PIM1MAP4K2DYRK3MAP4K4CDK1 | |
| SCHEMBL7055731 | 0.77 | CDK8 (1.00) | PIM1MAP4K2DYRK3MAP4K4CDK1 | |
| SCHEMBL7055551 | 0.77 | PIM1 (0.77) | PIM1MAP4K2DYRK3MAP4K4CDK1 | |
| SCHEMBL7055309 | 0.77 | CDK8 (0.59) | PIM1MAP4K2DYRK3MAP4K4CDK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030220365-A1 | Cell adhesion-inhibiting antiinflammatory compounds | STEWART ANDREW O (US) | 2003-11-27 | — | — | US | claimed |
| EP-1181296-A1 | CELL ADHESION-INHIBITING ANTIINFLAMMATORY COMPOUNDS | ABBOTT LABORATORIES (US) | 2002-02-27 | — | — | EP | claimed |
| US-20010020030-A1 | Cell adhesion-inhibiting antiinflammatory compounds | ABBVIE INC. | 2001-09-06 | — | — | US | claimed |
| EP-1090009-A2 | CELL ADHESION-INHIBITING ANTINFLAMMATORY COMPOUNDS | ABBOTT LABORATORIES (US) | 2001-04-11 | — | — | EP | claimed |
| WO-2000075145-A1 | CELL ADHESION-INHIBITING ANTIINFLAMMATORY COMPOUNDS | ABBOTT LABORATORIES (US) | 2000-12-14 | — | — | WO | claimed |
| WO-1999062908-A2 | CELL ADHESION-INHIBITING ANTINFLAMMATORY COMPOUNDS | ABBOTT LABORATORIES (US) | 1999-12-09 | — | — | WO | claimed |
| US-20030220365-A1 | Cell adhesion-inhibiting antiinflammatory compounds | STEWART ANDREW O (US) | 2003-11-27 | — | — | US | disclosed |
| US-6579882-B2 | Thieno(2,3-d)pyrimidine derivatives | ABBOTT LABORATORIES | 2003-06-17 | — | — | US | disclosed |
| EP-1181296-A1 | CELL ADHESION-INHIBITING ANTIINFLAMMATORY COMPOUNDS | ABBOTT LABORATORIES (US) | 2002-02-27 | — | — | EP | disclosed |
| US-20010020030-A1 | Cell adhesion-inhibiting antiinflammatory compounds | ABBVIE INC. | 2001-09-06 | — | — | US | disclosed |
| US-6232320-B1 | THIENO(2,3-C)PYRIDINE AND 5H-THIENO(2,3-C)PYRAN DERIATIVES | ABBOTT LABORATORIES | 2001-05-15 | — | — | US | disclosed |
| EP-1090009-A2 | CELL ADHESION-INHIBITING ANTINFLAMMATORY COMPOUNDS | ABBOTT LABORATORIES (US) | 2001-04-11 | — | — | EP | disclosed |
| WO-2000075145-A1 | CELL ADHESION-INHIBITING ANTIINFLAMMATORY COMPOUNDS | ABBOTT LABORATORIES (US) | 2000-12-14 | — | — | WO | disclosed |
| WO-1999062908-A2 | CELL ADHESION-INHIBITING ANTINFLAMMATORY COMPOUNDS | ABBOTT LABORATORIES (US) | 1999-12-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010020030-A1 | Cell adhesion-inhibiting antiinflammatory compounds | ICAM1, VCAM1, EPCAM | PIM1 2261/4885MAP4K2 2312/4885DYRK3 4878/4885 |
| US-20030220365-A1 | Cell adhesion-inhibiting antiinflammatory compounds | ICAM1, VCAM1, EPCAM | PIM1 2261/4885MAP4K2 2312/4885DYRK3 4878/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.